FINWIRES · TerminalLIVE
FINWIRES

研究快讯:CFRA维持对Capital Power Corp的“买入”评级,理由是其业绩指引稳健,且支出规模巨大。

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们维持对CPX的4星(买入)评级,并将12个月目标价下调至70加元,该目标价基于我们对2027年EBITDA的10.5倍预期市盈率计算得出。CPX的发电量增长并非没有代价,其在第一季度就已显现。尽管营收增长22%至12.05亿加元,发电量增长20%至11468吉瓦时(主要得益于2025年6月完成的Hummel Station和Rolling Hills的收购),但关键盈利指标却因巨额再投资而受到影响。调整后EBITDA增长10%至4.04亿加元,但AFFO下降29%至1.54亿加元。第一季度维持性资本支出较上年同期增长三倍,2026年停运天数将达到40%,虽然此前已向市场披露,但目前已在基本面中得到体现。不过,2026年的业绩指引保持不变,预计调整后营运资金(AFFO)为8.9亿至10.1亿加元,调整后息税折旧摊销前利润(EBITDA)为15.65亿至17.65亿加元。

Related Articles

Research

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

$BIO
Insider Trading

Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing

Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml

$FIX
Insider Trading

Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing

Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml

$KALU